New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

When considering the drugs most likely to cause former addicts to repeatedly relapse, opioids, cocaine, and methamphetamine ...

I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

An analysis of 2.2 million people reveals both shared and substance-specific genetic pathways for addiction risk, showing ...

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration (FDA) announced on July 29 it is taking action to restrict 7-OH opioid products threatening ...